Equities

Ilex Medical Ltd

ILX:TLV

Ilex Medical Ltd

Actions
Health CareMedical Equipment and Services
  • Price (ILa)6,333.00
  • Today's Change14.00 / 0.22%
  • Shares traded380.00
  • 1 Year change-8.35%
  • Beta-0.0048
Data delayed at least 20 minutes, as of Sep 26 2024 15:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ilex Medical Ltd is an Israel-based company active in the medical sector. It is a supplier of in vitro diagnostic equipment and laboratory management software. The Company offers cutting-edge diagnostic equipment and reagent systems; nucleic acid testing (NAT) blood screening solutions; products for cancer screening, retro virus load, TB, and STDs, and other infectious diseases; laboratory information systems (LIS); and blood sugar monitoring products. Among the Company’s subsidiaries and affiliates are Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd and Medtechnica Ltd.

  • Revenue in ILS (TTM)964.54m
  • Net income in ILS50.74m
  • Incorporated1990
  • Employees223.00
  • Location
    Ilex Medical LtdKodak Bldg7 Hatnufa St.,Kiriat Arie Indstrial ParkP.O.B 10249PETAH TIKVA 4951025IsraelISR
  • Phone+972 39385501
  • Fax+972 39385500
  • Websitehttps://www.ilexmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pulsenmore Ltd8.11m-52.04m200.52m76.00--1.71--24.73-0.9969-0.99690.15612.340.04290.22381.71106,684.20-27.53---29.70--34.04---641.80--10.65-8.780.1899---42.78---164.78------
Qatari German Co for Medical Device QPSC10.56m644.93k208.04m6.00322.735.5636.8419.700.00550.00550.09010.31950.05180.17490.212--0.3164-0.63950.5882-0.926658.2127.966.11-3.990.3345-0.60380.7937---34.7119.557.39--33.44--
Epitomee Medical Ltd37.35m-22.54m296.93m42.00--2.67--7.95-0.7576-0.75761.263.740.2341--40.65889,309.50-14.13---14.74-------60.35------0.1241------63.08------
Brainsway Ltd118.72m-15.68m518.69m106.00--3.33--4.37-0.4738-0.47383.594.670.49882.207.371,120,002.00-6.59-15.50-7.66-18.3573.8675.91-13.20-29.695.30--0.00--16.9614.1568.56--3.89--
Sofwave Medical Ltd206.75m-15.40m579.39m----6.19--2.80-0.45-0.456.042.731.362.966.16---10.10---15.33--75.21---7.45--2.18-11.080.047--41.22--57.61------
Ilex Medical Ltd964.54m50.74m706.98m223.0013.921.127.160.7334.544.5486.2056.200.98574.434.214,325,301.005.1913.846.8820.8923.6031.085.2612.172.00--0.078229.516.699.14-50.171.6116.32-11.34
Data as of Sep 26 2024. Currency figures normalised to Ilex Medical Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

12.99%Per cent of shares held by top holders
HolderShares% Held
Phoenix Provident Fund Ltd.as of 30 Sep 2023889.24k7.95%
Meitav Mutual Funds Ltd.as of 30 Jun 2024330.21k2.95%
Analyst IMS Mutual Funds Management (1986) Ltd.as of 30 Jun 202442.28k0.38%
Sigma Mutual Funds Ltd.as of 30 Jun 202436.72k0.33%
Yelin Lapidot Mutual Fund Management Ltd.as of 30 Jun 202430.67k0.27%
Dimensional Fund Advisors LPas of 05 Sep 202430.64k0.27%
Harel Mutual Funds Ltd.as of 30 Jun 202429.91k0.27%
Excellence Nessuah Mutual Funds Management Ltd.as of 30 Sep 202329.46k0.26%
Migdal Mutual Funds Ltd.as of 30 Jun 202422.76k0.20%
Ayalon Mutual Funds Ltd.as of 30 Jun 202411.13k0.10%
More ▼
Data from 26 Jun 2024 - 15 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.